Suppr超能文献

去甲肾上腺素通过β2-肾上腺素能受体减弱CXCR4表达及MDA-MB-231乳腺癌细胞的相应侵袭能力。

Norepinephrine attenuates CXCR4 expression and the corresponding invasion of MDA-MB-231 breast cancer cells via β2-adrenergic receptors.

作者信息

Wang L-P, Jin J, Lv F-F, Cao J, Zhang J, Wang B-Y, Shao Z-M, Hu X-C, Wang Z-H

机构信息

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

出版信息

Eur Rev Med Pharmacol Sci. 2015 Apr;19(7):1170-81.

Abstract

OBJECTIVE

The growing evidence from laboratory and clinical studies has shown that the stress hormone, norepinephrine, and chronic stress promote tumor progression in a variety of tumor types. Chemokines and chemokine receptors have been shown to play a pivotal role in tumor progression. Recently, norepinephrine was reported to have a significant effect on macrophage migration by altering the expression of the chemokine receptor CCR2.

MATERIALS AND METHODS

We investigated whether chemokines and their receptors are involved in the effects of norepinephrine on breast cancer. First, we used microarray analyses to detect the alteration of 128 chemotactically relevant genes after MDA-MB-231 cells were treated for 12 h with 100 μM norepinephrine. The CXCR4 gene demonstrated the greatest response to norepinephrine treatment, with a reduction of transcription of 95.7%, and was the focus of subsequent investigations. Real-time reverse transcription-PCR was used to determine the level of CXCR4 transcription after treatment with norepinephrine at various concentrations and for different durations.

RESULTS

The results revealed that norepinephrine reduced CXCR4 transcription in a dose-dependent manner. Norepinephrine was also found to exert a negative effect on CXCR4 translational expression, as evidenced by a 44 ± 1.7% reduction in expression after a 12-h treatment with 10 µM norepinephrine. A Matrigel assay demonstrated a 51.3 ± 9.1% reduction in the number of MDA-MB-231 cells driven to migrate by CXCR4. Finally, we found the specific β2-adrenergic antagonist, ICI 118,551, eliminated the impact of norepinephrine on CXCR4 expression.

CONCLUSIONS

Norepinephrine attenuates CXCR4 expression and the corresponding invasion of MDA-MB-231 tumor cells via the β2-adrenergic receptor. The complexity of the β2-adrenergic receptor signaling pathway might contribute to these unexpected observations in our research, and this justifies further investigation into the intricate mechanisms involved.

摘要

目的

来自实验室和临床研究的越来越多的证据表明,应激激素去甲肾上腺素和慢性应激会促进多种肿瘤类型的肿瘤进展。趋化因子和趋化因子受体已被证明在肿瘤进展中起关键作用。最近,据报道去甲肾上腺素通过改变趋化因子受体CCR2的表达对巨噬细胞迁移有显著影响。

材料与方法

我们研究了趋化因子及其受体是否参与去甲肾上腺素对乳腺癌的影响。首先,我们使用微阵列分析来检测MDA-MB-231细胞用100μM去甲肾上腺素处理12小时后128个趋化相关基因的变化。CXCR4基因对去甲肾上腺素处理的反应最大,转录减少了95.7%,是后续研究的重点。使用实时逆转录PCR来确定在不同浓度和不同持续时间的去甲肾上腺素处理后CXCR4转录水平。

结果

结果显示去甲肾上腺素以剂量依赖的方式降低CXCR4转录。还发现去甲肾上腺素对CXCR4翻译表达有负面影响,10μM去甲肾上腺素处理12小时后表达减少44±1.7%证明了这一点。基质胶试验表明,由CXCR4驱动迁移的MDA-MB-231细胞数量减少了51.3±9.1%。最后,我们发现特异性β2-肾上腺素能拮抗剂ICI 118,551消除了去甲肾上腺素对CXCR4表达的影响。

结论

去甲肾上腺素通过β2-肾上腺素能受体减弱CXCR4表达以及MDA-MB-231肿瘤细胞相应的侵袭。β2-肾上腺素能受体信号通路的复杂性可能导致了我们研究中这些意外的观察结果,这证明有必要进一步研究其中涉及的复杂机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验